Objective: We sought to find a combination of noninvasive treatments for snoring by adding weight loss to previously studied treatments, including the combination of sleeping on one's side and using a decongestant nasal spray. Study population: Twenty asymptomatic men who snore heavily were studied previously on a control night and on a night when they slept on their side and used a nasal spray. With these two treatments, minor improvements in apnea/hypopnea index (AHI) were seen, but no improvement occurred in snoring frequency. Nineteen of these subjects subsequently completed a 6-month weight loss program, and 12 lost weight. These 19 subjects comprise the study population of this report. Study design: At the conclusion of the weight loss program, a repeated sleep study was done from which the effect of adding weight loss to the two previously studied treatments could be assessed. hour with the addition of weight loss (p=0.15). The nine subjects who lost -3 kg reduced the number of snores per hour from 320 to 176 (p=0.0496). Three subjects losing an average of only 7.6 kg showed virtual elimination of snoring after weight loss. Subjects who gained weight had no improvement in snoring. Weight loss added to the other two modalities of treatment had no effect on the AHI. Conclusion: In most cases, the combination of weight loss, sleeping on one's side, and the administration of a nasal decongestant significantly reduces the frequency of snoring in asymptomatic men who snore heavily. The major effect appears to be related to weight loss. (Chest 1995; 107:1283-88) AHI=apnea/hypopnea index; BMI=body mass index; CI=confidence interval; SPT=sleep period time; TST=total sleep time
Objective: We sought to find a combination of noninvasive treatments for snoring by adding weight loss to previously studied treatments, including the combination of sleeping on one's side and using a decongestant nasal spray. Study population: Twenty asymptomatic men who snore heavily were studied previously on a control night and on a night when they slept on their side and used a nasal spray. With these two treatments, minor improvements in apnea/hypopnea index (AHI) were seen, but no improvement occurred in snoring frequency. Nineteen of these subjects subsequently completed a 6-month weight loss program, and 12 lost weight. These 19 subjects comprise the study population of this report. Study design: At the conclusion of the weight loss program, a repeated sleep study was done from which the effect of adding weight loss to the two previously studied treatments could be assessed. Results: Those 12 hour with the addition of weight loss (p=0.15). The nine subjects who lost -3 kg reduced the number of snores per hour from 320 to 176 (p=0.0496). Three subjects losing an average of only 7.6 kg showed virtual elimination of snoring after weight loss. Subjects who gained weight had no improvement in snoring. Weight loss added to the other two modalities of treatment had no effect on the AHI. Conclusion: In most cases, the combination of weight loss, sleeping on one's side, and the administration of a nasal decongestant significantly reduces the frequency of snoring in asymptomatic men who snore heavily. The major effect appears to be related to weight loss. (Chest 1995; 107:1283-88) General measures such as sleeping in the lateral position, using nasal decongestants, and weight loss have been shown to improve sleep apnea.6-8 None of those general measures should have unpleasant side effects and would likely be acceptable to the asymptomatic snorer. To our knowledge, no studies are available wherein the combination of these three general measures of treatment has been used in the same patient. Also, no studies have addressed the effectiveness of these therapies in asymptomatic snorers. In a previous study,9 we found a small but statistically significant improvement in the apnea/hypopnea index (AHI) of 20 asymptomatic male snorers by having them sleep in the lateral position and by the combination of sleeping in the lateral position and administering a nasal decongestant. There was no improvement in snoring in those subjects using the general measures of positional treatment, using a nasal decongestant, or the combination thereof. After the completion of the previous study,9 19 of the 20 subjects underwent a dietary weight loss program. The purpose of this study was to determine if the addition of weight loss to the small benefits seen in our previous study9 would be additive and yield more clinically impressive results.
MATERIALS AND METHODS
Nineteen of the 20 subjects previously described underwent a 6-month behavioral weight loss program. One subject moved out of the state and refused follow-up. The behavioral weight loss program entailed 24 weekly group sessions. Participants were taught behavioral procedures for dietary management, including self-monitoring, stimulus control, self-reinforcement, cognitive modification, and problem solving.'0 Nutritional recommendations included a balanced deficit diet, ie, 55% carbohydrate, 30% fat, and 15% protein, individually tailored to produce an expected weight loss of 0.45 to 0.9 kg/wk. Participants were taught to monitor their intake of macronutrients using both calorie counting and the exchange system of the American Diabetes Association. 11 During this 6-month period, all the subjects were instructed to spray their nose each night with oxymetazoline (Afrin), which was the nasal decongestant used in our previous study with these subjects. The subjects were also instructed to sleep in the lateral position at home, ensured by appropriately placed sandbags. After the completion of the weight loss program, all the subjects were monitored during a single night of sleep with methods similar to those used in our previous study.9 As in the previous study, the lateral position was secured with the use of foam rubber wedges both behind and in front of the subject. Television monitoring was used to assure that the lateral position was maintained during sleep. Also, as in the previous study, two sprays of oxymetazoline (Afrin) 12-h nasal spray were delivered to each nostril just prior to bedtime.
Continuous oxygen saturation was measured with an ear oximeter (Biox 3700, Ohmeda; Louisville, Colo). Oral and nasal airflows were monitored separately (Grass Thermistors, Quincy, Mass). Abdominal and chest movements were sensed with a respiratory inductance plethysmograph (Ambulatory Monitoring; Ardslet, NY), and a sum tracing was also recorded. The inductance tracing was not used quantitatively, but rather the deflections defined breathing rate and rhythm. Electroencephalograms and electro-oculograms were simultaneously recorded from occipital, frontal, and ocular leads. Electrocardiograms were recorded from a standard V2 lead. All leads were simultaneously recorded on a 15-channel polygraph with optical disk storage capability.
We again used a method to record and quantitate the frequency of snoring.9 12 At the initiation of our prior study,9 each subject underwent a brief history and physical examination that was performed by the principal investigator. The subjects were interviewed for their responses to a standardized series of questions to assure that they were healthy, had no symptoms that have been associated with the obstructive sleep apnea syndrome other than snoring, had no history of sinus disease or prior upper airway surgery, were not addicted to drugs or alcohol, and had no predisposing factors toward sleep apnea other than obesity.
Spouses were also similarly interviewed concerning symptoms of which the subject was unaware or which he denied. Work history was verified to assure that excessive sleepiness had not interfered with the subject's occupation. Subjects were included in the study only if they had a history of asymptomatic heavy snoring, were healthy, had no symptoms associated with the sleep apnea syndrome other than snoring, had no history or sinus disease or prior upper airway surgery, were not addicted to drugs or alcohol, had no predisposing factors toward sleep apnea other than obesity, and had normal results of pulmonary function tests. Recruitment of the subjects was quite easy through response to newspaper advertisements and through the use of lists of subjects from earlier studies. ' 
RESULTS
A total of 19 subjects entered and completed this study. All 19 of the subjects had previously fulfilled the enrollment criteria in our previous study.9 Demographic characteristics of the study group are shown in Table 1 . The degree of obesity of each patient was expressed in terms of body mass index (BMI) defined as weight/height where weight is expressed in kilograms and height in square meters.16
The BMI in the table represents the BMI for each patient prior to the initiation of our prior study.9
The mean weight loss ± SEM of the 12 subjects who lost weight during the dietary weight loss program was 8.0 ± 2.0 kg, (range, 2 to 20 kg). Table 2 reveals the sleep structure, including the mean ± SEM SPT, TST, and the percent of SPT spent in wakefulness, stages 1 and 2, stages 3 and 4, and rapid eye movement sleep during the control nights (zero modality), combination nasal spray/positional treatment nights (2 modality), and combination weight loss/nasal spray/positional treatment nights (3 modality) for the 19 subjects. Tables 3 and 4 reveal the actual number of snores per hour SPT, and AHI per hour SPT, respectively, for each subject. The amount of weight lost or gained by each subject during the dietary weight loss P VALUE IS VERSUS 0 MODALITY TREATMENT NUMBER = 12 SUBJECTS WHO LOST WEIGHT FIGURE 1. Bars represent the mean snores per hour SPT during the 0-modality, 2-modality, and 3-modality study nights for the 12 subjects who lost any amount of weight during the 6-month weight loss program. SPT=sleep period time. P value is vs 0 modality treatment.
program is recorded in the last column of Tables 3  and 4 . The first 12 subjects recorded in both tables lost the number of kilograms designated by a "-kg." The last seven subjects recorded in both tables gained the number of kilograms designated by a "+ kg."
As shown in Table 3 , three subjects (subjects 7, 8, and 9) who lost an average of only 7.6 kg of weight (range, 6 to 11 kg) had their snoring almost totally cured with the addition of only very mild weight loss to positional treatment and the administration of a nasal decongestant. Two subjects (subjects 10 and 11) shown in Table 3 continued to snore frequently even though they lost more weight than did subjects 7, 8, and 9 mentioned above.
If one looks at the three-modality night results for the 12 subjects who lost any amount of weight, there was a statistically significant improvement in the mean number of snores per hour as compared with the zero modality night (p=0.02) (Fig 1) . There was no statistically significant difference in the mean number of snores per hour in the two-modality treatment night compared with the three-modality treatment night (p=0.15) in those 12 subjects who lost any amount of weight. This lack of improvement in all 12 patients is clearly related to the aberrant results in patient 1, who did not snore on the two-modality night. During the zero modality night, the mean number of snores per hour ± SEM was 379 ± 60. During the two-modality treatment night, the mean number of snores per hour ± SEM was 328 ± 62 (95% CI, -58 to +159; p=0.33). During the three-modality treatment night, the mean number of snores per hour±SEM was 232±59 (95% CI, +28 to +265; p=0.02).
With the three-modality treatment, there was a statistically significant improvement in the mean SNORES / HOUR SPT number of snores per hour in those subjects who lost 23kg of weight compared with the two-modality treatment (Fig 2) . During the two-modality night, the mean number of snores per hour ± SEM was 320 ± 61. During the three-modality night, the mean number of snores per hour ± SEM was 176 ± 61 (95% CI, +0.3 to +288; p=0.0496).
In the seven subjects who gained weight during this study, the mean number of snores per hour ± SEM during the zero modality night was 361 ± 74. The mean number of snores per hour during the twomodality night was 431 ± 82 (95% CI, -145 to +4.9; p=0.06). The mean number of snores per hour ± SEM during the three-modality night was 396 ± 84 (95% CI, -192 to +122; p=0.60). If one looks at the two-and three-modality nights in the 12 subjects who lost weight during the weight loss program, there was a statistically significant improvement in the AHI as compared with the zero modality night (Fig 3) . There was no statistically significant improvement in the AHI in the two-modality group compared with the three-modality group (p=0.18). The mean AHI±SEM during the zero modality night was 18±7.6. The mean AHI ± SEM during the two modality treatment night was 14±7.2 (95% CI, +1.1 to +6.7; p=0.01). The mean AHI ± SEM during the 3 modality treatment night was 12±6.7; (95% CI, 0.8 to 11.0) p=0.02.
The mean AHI ± SEM during the control night in the seven subjects who gained weight was 18± 14. The mean AHI ± SEM during the two-modality treatment night in the seven subjects who gained weight was 14 + 13 (95% CI, -1.6 to +10.5; p=0.12). The mean AHI ± SEM during the three-modality treatment night in the seven subjects who gained weight was 15± 12 (95% CI, -3.7 to +9.7, p=0.32).
As shown in Table 4 , three subjects (subjects 5, 11, and 18) had a markedly elevated AHI. These subjects were included in the study because they fulfilled all of our inclusion criteria.
DISCUSSION
The general measures of weight loss, use of a nasal decongestant, and sleeping in the lateral position have each been shown to improve sleep apnea when used alone.6-8 We hypothesized that the combination of these treatments would be synergistic and perhaps cure the AHI The most surprising part of our study was that the addition of weight loss to sleeping in the lateral position and using a nasal decongestant had no additive effect on the AHI as compared with the combination of just sleeping in the lateral position and administering a nasal decongestant. In our previous study,9 we found that the combination of positional treatment and using a nasal decongestant improved, but did not normalize the AHI. Many studies have shown that weight loss can significantly improve obstructive sleep apnea. Smith et a123 showed that mild weight loss (averaging only 9.5 kg following caloric restriction) improved obstructive sleep apnea and sleep architecture and decreased daytime hypersomnolence. Suratt et a18 showed that moderate weight loss (averaging 21 kg following caloric restriction) reduced the frequency of disordered breathing events, improved oxygenation during wakefulness and sleep, and decreased nasopharyngeal collapsibility. Harman et a124 showed that surgically produced massive weight loss markedly improved sleep apnea and oxygen desaturation.
The most obvious reason why the AHI was not more significantly improved in our study was because of the very mild amount of weight our subjects were able to lose and because of the small number of subjects who actually lost weight. Obesity is thought to be a major factor causing upper airway obstruction during sleep and is present in most patients with obstructive sleep apnea. 25 Dieting is a very difficult challenge for many individuals. In fact, in a published study by Smith et al,23 only half of the subjects lost weight, and the amount of weight loss was only an average of 9.5 kg. We believe that if our study had included more subjects and a greater amount of weight loss had been obtained in the subjects, a marked improvement in the AHI would have been found to occur.
It should also be noted that in prior studies finding marked improvement in obstructive sleep apnea with weight loss,8,24 the position in which the subjects slept during their polysomnographic studies was not controlled. It is possible that the subjects in those prior studies who lost a considerable amount of weight8'24 could have actually changed to the lateral position during the sleep studies following their weight loss. The marked improvement in obstructive sleep apnea in those cases could therefore very well have been secondary to the combination of marked weight loss and sleeping in the lateral position.
In conclusion, on the basis of our study, it is obvious that the institution of the combination of positional treatment, nasal spray, and very mild weight loss can improve the AHI in the asymptomatic snorer. The combination of these three general measures reduces the frequency of snoring in most cases and in some cases almost totally cures the snoring of the asymptomatic snorer. The major benefit for snoring seems to be related to the loss of weight.
